Veradigm (MDRX) Akcija Цена

Veradigm Цена

NASDAQ·ZATVORENO
5,10
​
Tržište je zatvoreno

U poslednjih 20 godina prihod Veradigm rastao je 9,2 % godišnje i dostigao 588,02 М USD. Zarada po akciji rasla je 17,2 % godišnje u poslednjih 17 godina. Za Veradigm neto marža od -14,7 % je pala u odnosu na -11,2 % pre nekoliko godina. Konsenzusna 12-mesečna ciljana cena za Veradigm je 18,50 USD, oko iznad kurs za 262,7 %. Od 7 analitičara 6 preporučuje kupovinu — ukupni konsenzus je Kupi.

Cena akcije Veradigm

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

Veradigm poslovni model i analiza akcije

Allscripts Healthcare Solutions Inc je jedna od vodećih kompanija u sektoru digitalnog zdravstva u SAD-u. Kompanija je osnovana 1982. godine i od tada je postala jedan od najvažnijih pružalaca IT rešenja u zdravstvu. Allscripts pomaže pružaocima zdravstvenih usluga da unaprede negu pacijenata i efikasnost kroz razvoj i obezbeđivanje inovativnih softverskih i IT rešenja. Poslovni model Allscripts-a zasniva se na razvoju i prodaji web zasnovanih softverskih rešenja za medicinsku dokumentaciju i upravljanje bolnicama. Ova rešenja se prvenstveno distribuiraju bolnicama i ordinacijama putem pretplata ili licenci. Allscripts nudi širok spektar proizvoda koji su fokusirani na različite oblasti medicinske nege. Jedan od glavnih segmenata kompanije je sistem elektronskih zdravstvenih kartica (EHR). Ovaj sistem omogućava elektronsko beleženje, čuvanje i upravljanje medicinskim podacima i informacijama. To omogućava pružaocima zdravstvenih usluga da brzo i lako pristupe informacijama o pacijentima i dokumentuju važne dijagnoze i tretmane. Još jedan važan segment Allscripts-a je Upravljanje ciklusom prihoda (RCM), koji optimizuje procese fakturisanja i plaćanja u bolnicama i ordinacijama. Pored toga, Allscripts takođe nudi rešenja za telemedicinu, uključujući aplikacije pacijentskih portala, sisteme za daljinsko praćenje pacijenata i mobilne aplikacije za pacijente i pružioce usluga. Allscripts ima sedište u Čikagu i zapošljava preko 10.000 zaposlenih u različitim zemljama. Kompanija takođe održava partnerstva sa drugim kompanijama u sektoru zdravstva kako bi olakšala i poboljšala složenost digitalne transformacije na tržištu zdravstva. To uključuje kompanije poput Microsofta, koji zajedno sa Allscripts-om rade na razvoju veštačke inteligencije za zdravstvene aplikacije. Portfolijo ponude Allscripts-a je veoma širok i pruža kupcima raznovrsna softverska rešenja za različite oblasti medicinske nege. Proizvodi se posebno ističu korisničkim interfejsima, fleksibilnošću i skalabilnošću. Ovo omogućava kupcima da prilagode rešenja svojim specifičnim potrebama i uzmu u obzir buduće zahteve. Međutim, neki proizvodi su kritikovani zbog ograničenih mogućnosti proširenja, lošeg dizajna i sporog vremena učitavanja. Nedavno je Allscripts uložio značajna sredstva u istraživanje i razvoj kako bi rešio ove probleme i optimizovao aplikacije. Ukratko, Allscripts Healthcare Solutions Inc se smatra jednim od vodećih pružalaca softverskih i IT rešenja u zdravstvu u SAD-u. Zahvaljujući širokom asortimanu proizvoda i bliskoj saradnji sa partnerima u sektoru zdravstva, Allscripts je u stanju da svojim kupcima ponudi inovativna i skalabilna rešenja koja im pomažu da optimizuju poslovne procese i unaprede kvalitet svoje medicinske nege.

Često postavljana pitanja o akciji Veradigm

Allscripts Healthcare Solutions Inc is a leading healthcare technology company that provides innovative solutions and services to healthcare organizations. The business model of Allscripts revolves around the development and provision of electronic health record (EHR) systems, practice management software, and other healthcare IT solutions. By offering integrated platforms, Allscripts enables healthcare providers to streamline operations, improve patient care, and enhance clinical outcomes. With a focus on promoting interoperability and connectivity, Allscripts facilitates efficient data exchange across healthcare settings. By leveraging technology and data analytics, Allscripts aims to optimize workflows, enhance decision-making processes, and ultimately improve the overall delivery of healthcare services.

Allscripts Healthcare Solutions Inc is primarily active in the healthcare industry.

The main competitors of Allscripts Healthcare Solutions Inc in the market include Cerner Corporation, Epic Systems Corporation, and Meditech.

Allscripts Healthcare Solutions Inc is a leading healthcare information technology company established in 1986. The company features a rich history and background, having grown from a small startup to a global provider of electronic health records (EHR), practice management systems, and population health management solutions. Allscripts is dedicated to enhancing patient care by empowering healthcare organizations with innovative technology. With a strong presence in the healthcare industry, Allscripts serves over 180,000 physicians and more than 2,500 hospitals worldwide. Continuously evolving and expanding its offerings, Allscripts Healthcare Solutions Inc remains at the forefront of the digital healthcare revolution.

Allscripts Healthcare Solutions Inc has achieved several significant milestones in its history. The company has successfully launched innovative products, expanded its market share, and entered into strategic partnerships within the healthcare industry. Allscripts Healthcare Solutions Inc has also received industry recognition for its excellent performance and dedication to providing high-quality healthcare solutions. By continuously investing in research and development, the company has consistently improved its technology offerings, contributing to the overall advancement of healthcare services. With its commitment to excellence, Allscripts Healthcare Solutions Inc continues to shape the future of healthcare with its groundbreaking solutions and services.

Allscripts Healthcare Solutions Inc is primarily present in the United States of America.

Allscripts Healthcare Solutions Inc represents the values of innovation, collaboration, and patient-centered care. With a commitment to improving healthcare technology, Allscripts aims to transform the way healthcare is delivered and experienced. The company values a collaborative approach, working closely with healthcare providers and patients to develop solutions that enhance clinical outcomes and patient satisfaction. Allscripts prioritizes the use of advanced technology and data analytics to drive better healthcare decision-making and deliver personalized care. Through its comprehensive suite of software and services, Allscripts aims to empower healthcare organizations to deliver efficient, high-quality care to their patients.

Analitičari trenutno postavljaju prosečnu ciljanu cenu 16,17 USD za akciju Veradigm (medijana: 18,50 USD), što znači +226,7 % u odnosu na poslednju cenu. Konsenzus se zasniva na 7 ocena.

7 analitičara trenutno ocenjuje akciju Veradigm: 6 preporučuje kupovinu, 1 držanje i 0 prodaju.

Po trenutnom kursu akcija Veradigm kotira 4,64 EUR (5,10 USD).

Akcija Veradigm (MDRX) kotira na 4 berze, uključujući: NASDAQ (MDRX), Frankfurt (AL21.F), München (AL21.MU), Düsseldorf (AL21.DU).

Allscripts Healthcare Solutions Inc is an American company specializing in providing IT solutions for healthcare providers. The company was founded in 1986 as a small software firm in Chicago and has since become one of the leading providers of electronic health records and other health IT solutions. Allscripts offers a wide range of products and services to meet the needs of healthcare providers of all sizes and types. The various business areas of Allscripts include hospitals and health systems, physician practices, accountable care organizations (ACOs), and pharmacies. Allscripts' products and services are designed to increase the efficiency of healthcare providers, improve the quality of patient care, and meet the growing demand for connected healthcare. In the hospital and health systems area, Allscripts offers a comprehensive portfolio of solutions to meet the complex requirements of large and complex health systems. This includes electronic health records, laboratory and imaging management, portfolio management, revenue cycle management, and reporting. In the physician practices area, Allscripts provides a variety of solutions to increase the efficiency of individual practices and smaller group practices. Products in this area include electronic health records, appointment scheduling, billing, prescription management, and patient portals. For ACOs, Allscripts offers a variety of solutions to support the community of healthcare facilities and providers. This includes solutions for collaboration management, population health management, and the automation of clinical workflows. Allscripts' solutions are also of interest to pharmacies. Allscripts offers solutions for optimizing inventory management, billing, and patient care. The company relies on state-of-the-art IT solutions and implements industry-leading methods for data analysis. Allscripts employs over 8,600 employees and has customers in over 190 countries. The company demonstrates its commitment to innovation in the healthcare industry through the development of new products and services. For example, a program to enhance the functionality of implanted pacemakers was recently introduced, which can be operated directly from a smartphone via a secure cloud system. With the introduction of new products and solutions, Allscripts aims to further expand its business in the healthcare sector and strengthen its position as a leading provider of health IT solutions. In summary, Allscripts Healthcare Solutions Inc is a leading provider of health IT solutions that offers a wide range of products and services for healthcare providers of all sizes and types. Allscripts aims to make healthcare more sustainable, digital, and connected, and to increase the efficiency of the healthcare system through innovative solutions.

Prihod se trenutno ne može izračunati za Veradigm.

očekivana dobit od Veradigm je 32,67 М USD. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.

Odnos cene i zarade (KGV) za Veradigm je trenutno 20,12. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Veradigm.

KUV se trenutno ne može izračunati za Veradigm.

Eulpool score kvaliteta za Veradigm je 0/10.

ISIN za Veradigm je US01988P1084. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.

WKN za Veradigm je 607917. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.

Ticker za Veradigm je MDRX. Simbol tikera se koristi za trgovinu akcijama Veradigm na berzanskom tržištu.

Фер вредностTerminal
5,10 USD
Над-/ПодцењеностTerminal
Адекватно вредна
Сектор
Индустрија
Здравствена технологија
Број акција
Запослени
Приход по запосленом
255.659,57 USD
Раст прихода Ø5 година
Раст EBIT Ø5 година
Раст нето добити Ø5 година
Веб сајт allscripts.com
Валута
USD
Јавна понуда
23. јул 1999.
ISIN
US01988P1084
CUSIP
01988P108
SEDOL
2710039
Тржишна капитализација
555,39 М USDSmall Cap
Опсег од 52 недеље
AAQS
0 / 10
PEG
-0,36
P/E однос
P/Ee 2025
20,32
P/Ee 2026
17,00
P/Ee 2027
11,86
P/Ee 2028
9,62
P/Ee 2029
7,73
P/S
P/Se
—
EV/EBIT
—
P/B однос
0,55
ROE (Поврат на капитал)
ROA (Поврат на имовину)
ROCE (Поврат на ангажовани капитал)
ROIC (Поврат на уложени капитал)
-6,99 %
Zadnje ažurirano 21. нов 2026. 11:15

Veradigm Тикер

DISELORF · AL21.DUFRANKFURT · AL21.FMINHEN · AL21.MUNASDAQ · MDRX

Veradigm FIGI

AL21:GR · BBG000BGHS83AL21:GF · BBG000BGHSG4AL21:GD · BBG000BGHSQ3AL21:GS · BBG000BGHTB7AL21:GM · BBG000BGHTK7AL21:GB · BBG000BGHTW4MDRX:US · BBG000BLDXH5MDRX:UA · BBG000BLDY38MDRX:UC · BBG000BLDYD7MDRX:UN · BBG000BLF094MDRX:UP · BBG000BLF0J3MDRX:UB · BBG000BLF129

Sve ključne metrke i detaljne analize Veradigm u dubinskoj analizi

Naša analiza akcija za akciju Veradigm uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Veradigm. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: